We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Light-Activated Expanding Implant to Eliminate Open-Chest Surgeries for Shunt Replacement in Children

By HospiMedica International staff writers
Posted on 21 Aug 2024

Children born with congenital heart defects that impact the heart’s lower chambers often require multiple invasive surgeries early in life. More...

The initial procedure typically involves implanting a plastic tube known as a shunt to enhance blood flow. As the child grows, this shunt frequently needs replacement to match their changing body size, leading to additional surgeries. Now, researchers have developed a shunt that can be expanded using light, marking a breakthrough that could reduce the number of open-chest surgeries these children have to undergo.

Congenital defects in the ventricles, or lower chambers of the heart, severely restrict blood flow to the lungs and body, necessitating surgical intervention for survival. Infants affected by these defects are often small at birth but can grow quickly after the initial shunt placement. To keep pace with their growth, repeated surgeries are required to implant larger shunts. Each surgery carries significant risks for the child. Previously, researchers at Drexel University (Philadelphia, PA, USA) had developed a prototype shunt that could expand by incorporating a hydrogel with polymers connected by crosslinks inside the tube. These crosslinks, when new ones formed, would expel water from the hydrogel, causing it to contract and thereby expand the shunt’s diameter. Initially, this process occurred automatically without external activation.

In their latest research, the team redesigned the shunt to use materials suitable for clinical applications and adjustable to individual needs. They engineered a new type of hydrogel that forms crosslinks in response to an external trigger, thereby increasing the diameter of the shunt. They chose blue light as the trigger because it has sufficient energy to start the reaction while being safe for living tissues. The researchers used a fiber-optic catheter with a light-emitting tip to activate the hydrogel. Surgeons can activate the light-sensitive hydrogel inside the shunt by inserting the catheter through an artery near the armpit and guiding it to the shunt, thus avoiding open-chest surgery.

Laboratory tests demonstrated that the shunt could be expanded incrementally based on the duration of light exposure, suggesting that post-implantation adjustments could be tailored to each child’s growth needs. They achieved up to a 40% dilation of the shunt, increasing its diameter from 3.5 millimeters to 5 millimeters. The team also evaluated the biocompatibility of the shunt, finding no significant risk of blood clots, inflammatory responses, or other adverse effects. Future plans include testing full-length prototypes in a synthetic model of the human circulatory system and later in animal models. The researchers believe this technology could also be adapted for other uses, such as replacing blood vessels in children who have sustained injuries.

“Our goal is to expand the inside of the tube with a light-emitting catheter that we insert inside the shunt, completely eliminating the need for additional surgeries,” said Christopher Rodell, an assistant professor of biomedical engineering at Drexel University. “Children aren’t just tiny adults; they continue to grow. That’s something we need to account for in biomaterials, how that graft will behave over time.”

Related Links:
Drexel University


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Shoulder System
Identity Shoulder System
New
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.